Quantcast

Latest Methicillin-resistant Staphylococcus aureus Stories

2014-10-20 23:02:14

With the Ebola threat spreading, decontamination robots have been called to duty in Dallas to disinfect areas within the hospital that were exposed to the first documented case of Ebola in the United States. The remote controlled robotic decontamination systems made by the biotech company, Bioquell, have been used in a variety of places around the world to combat the current outbreak including the National Institutes of Health. Horsham, PA October 16, 2014 (PRWEB) October 20, 2014 With...

2014-10-17 23:03:14

Company officials available to comment on work being done to ensure safe hospital facilities where Ebola patients are treated. Horsham, PA (PRWEB) October 17, 2014 Bioquell, provider of germ-eliminating robots and services, is being called upon by health facilities around the world to decontaminate locations where Ebola-infected and exposed patients are being treated. Among the many places the hydrogen peroxide vapor technology is being used includes Texas Health Presbyterian Hospital...

2014-10-15 16:29:09

LONDON, Oct. 15, 30, 2014 /PRNewswire/ -- Infections from activities and procedures taking place within a healthcare facility have become a cause for great concern. These infection may occur in a postoperative wound or as a complication unrelated to the disease or condition. This report, Healthcare-Associated Infection (HAI) Control Markets: focuses on the market opportunities for companies that can assist hospitals and other healthcare facilities with important HAI mitigation tasks...

Study Shows Hospitalized Patients Don't Wash Their Hands Enough
2014-10-09 03:57:16

Provided by McMaster University Hospital visitors and staff are greeted with hand sanitizer dispensers in the lobby, by the elevators and outside rooms as reminders to wash their hands to stop infections, but just how clean are patients' hands? A study led by McMaster University researcher Dr. Jocelyn Srigley has found that hospitalized patients wash their hands infrequently. They wash about 30 per cent of the time while in the washroom, 40 per cent during meal times, and only three...

2014-10-08 08:26:16

VIENNA and PHILADELPHIA, October 8, 2014 /PRNewswire/ -- Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant Gram-positive and Gram-negative pathogens, announced today that the United States Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) as well as Fast Track status designation to Nabriva's lead product lefamulin,...

2014-10-07 08:29:40

LAUSANNE, Switzerland, October 7, 2014 /PRNewswire/ -- Debiopharm Group(TM)(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, announced today excellent progress of its Phase I single and multiple ascending dose study of Debio 1450, a highly potent anti-infective agent selectively active against Staphylococcus species, including all known resistant strains such as...

2014-10-06 23:01:58

Topical report “Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014” worked out by Global Markets Direct is now available at MarketPublishers.com. London, UK (PRWEB) October 06, 2014 Hospital-acquired methicillin-resistant Staphylococcus aureus (HA-MRSA) is potentially lethal strain of Staph aureus which is resistant to some antibiotics. This superbug has become a frequent guest in many medical facilities, representing a surging...

2014-10-06 08:28:37

- Lead Product DALVANCE(TM) a Novel Antibiotic for Unmet Medical Need in Hospital and Outpatient Settings - DUBLIN, Ireland and CHICAGO, Oct. 6, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, and Durata Therapeutics, Inc. (NASDAQ: DRTX), an innovative pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses, today announced that they...

2014-10-06 08:28:03

Company Completes Enrollment in Phase 2 Clinical Trial AUSTIN, Texas, Oct. 6, 2014 /PRNewswire/ -- Savara Pharmaceuticals announced today that it closed a $10 million bridge financing round to support the development of AeroVanc, the first inhaled antibiotic being developed to address the growing number of methicillin-resistant Staphylococcus aureus (MRSA) lung infections in people with cystic fibrosis (CF). Previous investors participated in the financing, and new investors include...

2014-10-02 16:26:37

ROUND ROCK, Texas, Oct. 2, 2014 /PRNewswire/ -- Antibiotic options are becoming limited by drug-resistant pathogens, creating a "serious domestic and international challenge to human and animal health, national security and the economy," said John Holdren, director of the White House Office of Science and Technology Policy at a September press conference. In laying out the White House's plan to fight antibiotic misuse, Mr. Holdren said that up to half of all antibiotics prescribed are not...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin